PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pediatrics-Human Gene Therapy, Stanford University School of Medicine, Stanford, CA, USA.\', \'Stanford Immunology, Stanford University School of Medicine, Stanford, CA, USA.\', \'Department of Immunology, Henan University of Science and Technology School of Medicine, Luoyang, China.\', \'Department of Pediatrics-Human Gene Therapy, Stanford University School of Medicine, Stanford, CA, USA. wjiang6@stanford.edu.\', \'Stanford Immunology, Stanford University School of Medicine, Stanford, CA, USA. wjiang6@stanford.edu.\', \'Department of Pediatrics-Human Gene Therapy, Stanford University School of Medicine, Stanford, CA, USA. mellins@stanford.edu.\', \'Stanford Immunology, Stanford University School of Medicine, Stanford, CA, USA. mellins@stanford.edu.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41423-021-00717-5
?:doi
?:hasPublicationType
?:journal
  • Cellular & molecular immunology
is ?:pmid of
?:pmid
?:pmid
  • 34117370
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Yeast display of MHC-II enables rapid identification of peptide ligands from protein antigens (RIPPA).
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all